Literature DB >> 16030119

Total cholesterol and body mass index in relation to 40-year cancer mortality (the Corfu cohort of the seven countries study).

Demosthenes B Panagiotakos1, Christos Pitsavos, Evangelos Polychronopoulos, Christina Chrysohoou, Alessandro Menotti, Anastasios Dontas, Christodoulos Stefanadis.   

Abstract

PURPOSE: We evaluated risk factors of cancer mortality based on a 40-year follow-up of the Corfu cohort (Seven Countries Study).
MATERIAL AND METHODS: The population studied in this analysis consisted of 529 rural men (49 +/- 6 years old) enrolled in 1961. Since then, periodic visits every 5 years were made to define the causes of death of the participants. Cox proportional hazards models evaluated various risk factors in relation to cancer mortality.
RESULTS: The death rate at the end of the follow-up was 87.1% (i.e., 461 deaths in 529 participants). Of those deaths, 118 (25.6%) were because of cancer (30 deaths were due to cancer of trachea, bronchus, and lung, and the rest were due to other malignant neoplasms). Cancer was the second cause of death in this cohort, after coronary heart disease. Age (hazard ratio, 1.05 per year; P < 0.05), smoking (hazard ratio, 1.97; P < 0.01), total serum cholesterol levels (hazard ratio, 0.95 per 10 mg/dL; P < 0.05), and body mass index (hazard ratio, 0.93 per 1 kg/m2; P < 0.05) showed a significant association with cancer deaths after controlling for physical activity status and anthropometric indices. It should be noted that the protective effect of total cholesterol on cancer mortality was observed only between 183 and 218 mg/dL baseline levels.
CONCLUSION: Cancer was one of the leading causes of death in this cohort. Smoking was associated with increased risk of cancer, whereas moderate total serum cholesterol and increased body and mass index seemed to have a protective effect on 40-year cancer mortality.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16030119     DOI: 10.1158/1055-9965.EPI-04-0907

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  9 in total

Review 1.  The complex interplay between cholesterol and prostate malignancy.

Authors:  Keith R Solomon; Michael R Freeman
Journal:  Urol Clin North Am       Date:  2011-06-22       Impact factor: 2.241

2.  Serum low-density lipoprotein levels correlate with survival in advanced stage epithelial ovarian cancers.

Authors:  Andrew J Li; R Geoffrey Elmore; Ida Yii-der Chen; Beth Y Karlan
Journal:  Gynecol Oncol       Date:  2009-10-12       Impact factor: 5.482

3.  Time-dependent association of total serum cholesterol and cancer incidence in a cohort of 172,210 men and women: a prospective 19-year follow-up study.

Authors:  A M Strasak; R M Pfeiffer; L J Brant; K Rapp; W Hilbe; W Oberaigner; S Lang; W Borena; H Concin; G Diem; E Ruttmann; B Glodny; K P Pfeiffer; H Ulmer
Journal:  Ann Oncol       Date:  2009-01-22       Impact factor: 32.976

4.  Comment on 'Statin use and all-cancer survival: prospective results from the Women's Health Initiative'.

Authors:  Luca Mascitelli; Mark R Goldstein
Journal:  Br J Cancer       Date:  2016-12-06       Impact factor: 7.640

5.  Preoperative serum lipid profile and outcome in nonmetastatic colorectal cancer.

Authors:  Ting-Ting Hong; Di Shen; Xiao-Ping Chen; Xiao-Hong Wu; Dong Hua
Journal:  Chronic Dis Transl Med       Date:  2016-12-22

6.  Association of dyslipidemia with renal cell carcinoma: a 1∶2 matched case-control study.

Authors:  Chunfang Zhang; Luping Yu; Tao Xu; Yichang Hao; Xiaowei Zhang; Zhenhua Liu; Yunbei Xiao; Xiaofeng Wang; Qiang Zeng
Journal:  PLoS One       Date:  2013-03-25       Impact factor: 3.240

Review 7.  Influence of liver cancer on lipid and lipoprotein metabolism.

Authors:  Jingting Jiang; Peter Nilsson-Ehle; Ning Xu
Journal:  Lipids Health Dis       Date:  2006-03-03       Impact factor: 3.876

8.  Expression of NR1H3 in endometrial carcinoma and its effect on the proliferation of Ishikawa cells in vitro.

Authors:  Fang Fang; Dawei Li; Lu Zhao; Yue Li; Teng Zhang; Baoxia Cui
Journal:  Onco Targets Ther       Date:  2019-01-18       Impact factor: 4.147

Review 9.  The Role of Metabolic Factors in Renal Cancers.

Authors:  Jacek Rysz; Beata Franczyk; Janusz Ławiński; Robert Olszewski; Anna Gluba-Brzózka
Journal:  Int J Mol Sci       Date:  2020-09-30       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.